Japer Therapeutics Warrants
JSPRW
4 hedge funds and large institutions have $538K invested in Japer Therapeutics Warrants in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
128% more capital invested
Capital invested by funds: $236K → $538K (+$302K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.02% less ownership
Funds ownership: 2.67% → 2.65% (-0.02%)
33% less funds holding
Funds holding: 6 → 4 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$39.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$15.7K |
| 2 |
CL
CSS LLC
Chicago,
Illinois
|
-$6.56K |
| 3 |
ZA
Zazove Associates
Incline Village,
Nevada
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAC
1
Cowen and Company
New York
| $382K | +$39.6K | +248,828 | +13% |
|
|
2
Walleye Capital
New York
| $108K | -$15.7K | -99,000 | -14% |
|
|
TCM
3
Tenor Capital Management
New York
| $45.5K | – | – | – |
|
4
Walleye Trading
New York
| $2.56K | – | – | – |
|
|
CL
5
CSS LLC
Chicago,
Illinois
| – | -$6.56K | -81,957 | Closed |
|
|
ZA
6
Zazove Associates
Incline Village,
Nevada
| – | -$5K | -65,456 | Closed |
|
JSPRW Hedge Fund Activity: Q1 2024 in Review
4 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q1 2024, worth a combined $538K — up 128% from $236K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of JSPRW and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Cowen and Company, adding an estimated $39.6K. The largest seller was Walleye Capital, cutting an estimated $15.7K.
- 4 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q1 2024, down from 6 in Q4 2023.
- Funds reported $538K of Japer Therapeutics Warrants stock for Q1 2024, up 128% quarter-over-quarter.
- 0 funds opened new Japer Therapeutics Warrants positions in Q1 2024 and 2 closed out, a net change of -2 holders.
- The largest Japer Therapeutics Warrants buyer in Q1 2024 was Cowen and Company, an estimated $39.6K added.
- The largest Japer Therapeutics Warrants seller in Q1 2024 was Walleye Capital, an estimated $15.7K sold.
Based on aggregated 13F filings for Q1 2024.